Literature DB >> 2579015

Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases.

D D Weisenburger, B N Nathwani, C D Winberg, H Rappaport.   

Abstract

A clinicopathologic analysis of 16 cases of multicentric angiofollicular lymph node hyperplasia (MAFH) was performed. Histologically, the disease was characterized by recognizable lymph node architecture that was at least partially intact, by paracortical hyperplasia with prominent vascular proliferation, and by numerous evenly distributed, apparently benign germinal centers of various types, usually including some typical hyaline-vascular centers. At the onset of the disease, 12 patients had the plasma cell (PC) type of MAFH, three patients had the hyaline-vascular (HV) type, and one patient presented with PC and HV types at separate sites. Transitions between the PC and HV types were observed in two cases. Immunologic studies demonstrated polyclonal populations of plasma cells in the lymph nodes of all patients and the absence of suppressor T lymphocytes in the one patient tested. Clinically, the patients had constitutional symptoms, multicentric lymphadenopathy, hepatosplenomegaly in many cases, and abnormal laboratory findings, including anemia, polyclonal hypergammaglobulinemia, and bone marrow plasmacytosis. The 16 patients were placed in four different clinical groups based on presentation and course: stable disease, chronic relapsing disease, aggressive disease, and development of malignant lymphoma. Ten of the 16 patients died (median survival, 26 months; range, eight to 170 months). Multicentric angiofollicular lymph node hyperplasia appears to be a variant of classic angiofollicular lymph node hyperplasia (Castleman's disease) and is associated with significant morbidity and mortality.

Entities:  

Mesh:

Year:  1985        PMID: 2579015     DOI: 10.1016/s0046-8177(85)80065-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  53 in total

Review 1.  Portal hypertension and refractory ascites associated with multicentric Castleman's disease.

Authors:  M Abarca; R J Andrade; A García-Arjona; J L Escolar; A Blanes; J M García-Hirschfeld; P González-Santos
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  K A Staskus; R Sun; G Miller; P Racz; A Jaslowski; C Metroka; H Brett-Smith; A T Haase
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Giant lymph node hyperplasia of the lung (Castleman's disease) associated with recurrent pleural effusion.

Authors:  A A Awotedu; B A Otulana; C O Ukoli
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

4.  Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients.

Authors:  Y Baruch; Y Ben-Arie; H Kerner; M Lorber; L A Best; R Gershoni-Baruch
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

5.  Assessment of pathologically diagnosed patients with Castleman's disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease.

Authors:  Takaaki Ogoshi; Takashi Kido; Kazuhiro Yatera; Keishi Oda; Toshinori Kawanami; Hiroshi Ishimoto; Noriho Sakamoto; Arisa Sano; Chiharu Yoshii; Shohei Shimajiri; Hiroshi Mukae
Journal:  Lung       Date:  2013-08-13       Impact factor: 2.584

Review 6.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

7.  Castleman's disease of the left parotid gland: a case report.

Authors:  Zhenfei Guo; Chang Liu; Jing Sun; Linggong Zeng; Kai Zhang
Journal:  Int J Clin Exp Pathol       Date:  2021-04-15

8.  Angiofollicular lymph node hyperplasia with amyloidosis.

Authors:  K P West; D R Morgan; I Lauder
Journal:  Postgrad Med J       Date:  1989-02       Impact factor: 2.401

9.  Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.

Authors:  A Tavoni; C Vitali; P Baglioni; R Gerli; G Marchetti; O Di Munno; S Bombardieri
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  Meningeal Castleman's disease with multifocal involvement: a case report and review of literature.

Authors:  Santiago Coca; Isabel Salas; Roberto Martínez; Miguel Angel Saez; Jesús Vaquero
Journal:  J Neurooncol       Date:  2008-01-18       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.